SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001214659-23-007852
Filing Date
2023-05-26
Accepted
2023-05-25 21:53:12
Documents
2
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 r5252326ka2.htm 6-K/A 21509
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 241371
  Complete submission text file 0001214659-23-007852.txt   264005
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-37652 | Film No.: 23962815
SIC: 2834 Pharmaceutical Preparations